Artelo Biosciences's market cap is currently $7.82M. The company's EPS TTM is $-5.61; its P/E ratio is ―; Artelo Biosciences is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.82. See an overview of income statement, balance sheet, and cash flow financials.
